079f2816_BiblioServet__Guidance
[Reference] TA343 [Programme] Technology appraisal guidance [Topic] Blood and bone marrow cancers [Guidance] 
Obinutuzumab in combination with chlorambucil for untreated chronic lymphocytic leukaemia
BiblioServet
Guidance